Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.03
-$0.08 (-2.57%)
At close: Sep 21, 2026, 4:00 PM ET
$3.05
+$0.02 (+0.66%)
Pre-market:
Sep 22, 2026, 8:14 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 26.87M | 26.87M | 26.87M | 67.43M | 40.56M | 40.56M | 40.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 151K | 151K | n/a | n/a | n/a | n/a | 324K | 324K | 324K | 324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -151K | -151K | n/a | 26.87M | 26.87M | 26.87M | 67.1M | 40.24M | 40.24M | 40.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -191.23M | -145.04M | -152.81M | -165.26M | -182.96M | -212.05M | -191.19M | -209.27M | -220.55M | -259.32M | -299.51M | -283.34M | -274.82M | -234.36M | -227.29M | -223.73M | -232.4M | -224.07M | -216.54M | -208.59M | -180.49M | -152.74M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 493 | 493 | 493 | 493 | n/a | n/a | n/a | 143K | 143K | 143K | 143K |
Pretax Income | -174.08M | -123.57M | -136.62M | -149.52M | -163.02M | -224.15M | -165.69M | -179.09M | -194.41M | -219.57M | -292.91M | -287.18M | -286.33M | -241.53M | -237.58M | -232.17M | -188.7M | -175.35M | -166.39M | -156.38M | -179.84M | -152.12M |
Net Income | -174.9M | -124.13M | -137.06M | -149.32M | -162.78M | -224.19M | -165.84M | -179.28M | -194.65M | -218.9M | -292.19M | -286.25M | -285.12M | -240.95M | -236.81M | -231.89M | -181.68M | -167.9M | -158.73M | -148.97M | -179.33M | -151.62M |
Selling & General & Admin | 46.04M | 34.97M | 36.57M | 68.67M | 72.49M | 81.96M | 86.79M | 63.15M | 64.5M | 63.4M | 64.35M | 59.12M | 55.18M | 59.16M | 54.55M | 53.17M | 50.03M | 40.76M | 40.94M | 41.91M | 43.14M | 42.7M |
Research & Development | 145.03M | 108.76M | 107.3M | 110.78M | 124.65M | 145.43M | 167.77M | 186.35M | 196.29M | 190.59M | 189.59M | 178.65M | 174.07M | 175.21M | 172.73M | 170.56M | 182.37M | 183.32M | 175.6M | 166.68M | 137.36M | 110.04M |
Other Expenses | n/a | 1.15M | 8.95M | 12.68M | 12.68M | 11.53M | 3.74M | n/a | n/a | 45.57M | 45.57M | 45.57M | 45.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 191.08M | 144.89M | 152.81M | 192.13M | 209.83M | 238.92M | 258.29M | 249.5M | 260.79M | 299.56M | 299.51M | 283.34M | 274.82M | 234.36M | 227.29M | 223.73M | 232.4M | 224.07M | 216.54M | 208.59M | 180.49M | 152.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 345K | 345K | 345K | 345K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -151K | -151K | n/a | n/a | n/a | n/a | -324K | -324K | -324K | -324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 191.23M | 145.04M | 152.81M | 192.13M | 209.83M | 238.92M | 258.62M | 249.83M | 261.11M | 299.88M | 299.51M | 283.34M | 274.82M | 234.36M | 227.29M | 223.73M | 232.4M | 224.07M | 216.54M | 208.59M | 180.49M | 152.74M |
Income Tax Expense | 820K | 562K | 442K | -205K | -232K | 34K | 177K | 247K | 305K | -566K | -601K | -826K | -1.02M | -394K | -469K | 50K | -488K | -460K | -297K | -30K | 685K | 640K |
Shares Outstanding (Basic) | 70.26M | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 70.9M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
Shares Outstanding (Diluted) | 70.26M | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 71.19M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
EPS (Basic) | -2.46 | -1.73 | -1.90 | -2.08 | -2.27 | -3.14 | -2.33 | -2.52 | -2.75 | -3.36 | -4.53 | -4.48 | -4.61 | -3.99 | -4.23 | -4.53 | -3.70 | -3.81 | -3.78 | -3.68 | -4.50 | -3.94 |
EPS (Diluted) | -2.46 | -1.73 | -1.90 | -2.08 | -2.27 | -3.14 | -2.33 | -2.52 | -2.75 | -3.36 | -4.53 | -4.48 | -4.61 | -3.99 | -4.23 | -4.53 | -3.70 | -3.81 | -3.78 | -3.68 | -4.50 | -3.94 |
EBITDA | -173.46M | -130.98M | -133.46M | -144.64M | -157.97M | -210.91M | -162.84M | -177.78M | -193.08M | -163.4M | -236.7M | -230.6M | -229.72M | -239.75M | -235.81M | -219.16M | -175.92M | -162.79M | -154.2M | -156.43M | -180.09M | -152.53M |
EBIT | -174.08M | -131.6M | -134.2M | -145.54M | -159.03M | -212.14M | -164.13M | -179.09M | -194.41M | -164.75M | -238.09M | -232.01M | -231.16M | -241.19M | -237.24M | -220.43M | -176.96M | -163.6M | -154.75M | -156.8M | -180.38M | -152.74M |
Depreciation & Amortization | 621K | 628K | 739K | 899K | 1.06M | 1.23M | 1.29M | 1.31M | 1.34M | 1.35M | 1.39M | 1.41M | 1.44M | 1.44M | 1.43M | 1.28M | 1.04M | 809K | 544K | 368K | 282K | 201K |
Add to Watchlist
Select watchlists to add or remove ZNTL